Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Activation of Bruton tyrosine kinase (BTK) and phosphatidylinositol-3-kinase (PI3K) represent parallel, synergistic pathways in lymphoma pathogenesis. As predominant PI3Kδ inhibition is a possible mechanism of tumor escape, we proposed a clinical trial of dual BTK and pan-PI3K inhibition. We conduct...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2022-01, Vol.28 (1), p.45-56
Hauptverfasser: Stewart, Caitlin M, Michaud, Laure, Whiting, Karissa, Nakajima, Reiko, Nichols, Chelsea, De Frank, Stephanie, Hamlin, Jr, Paul A, Matasar, Matthew J, Gerecitano, John F, Drullinsky, Pamela, Hamilton, Audrey, Straus, David, Horwitz, Steven M, Kumar, Anita, Moskowitz, Craig H, Moskowitz, Alison, Zelenetz, Andrew D, Rademaker, Jurgen, Salles, Gilles, Seshan, Venkatraman, Schöder, Heiko, Younes, Anas, Tsui, Dana W Y, Batlevi, Connie Lee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!